Sackett R L, McCusker R H
The Department of Animal Sciences, The University of Illinois, Urbana 61801, USA.
Endocrinology. 1998 Apr;139(4):1943-51. doi: 10.1210/endo.139.4.5924.
The current studies quantified the effect of the multivalent cations zinc, cadmium, lanthanum, chromium, and gold (Zn2+, Cd2+, La3+, Cr3+, and Au3+) on [125I]-insulin-like growth factor ([125I]-IGF) binding to T98G human glioblastoma cells. The major binding site for the IGFs on T98G cells is IGF binding protein-5 (IGFBP-5), as determined by affinity labeling. Competitive binding studies, using either [125I]-IGF-I or [125I]-IGF-II, indicated that La3+ and Cr3+ did not affect [125I]-IGF-I or [125I]-IGF-II binding to cell-associated IGFBP-5. Zn2+, Au3+, and Cd2+ depressed binding of both [125I]-IGF-I and [125I]-IGF-II. [125I]-IGF-I and [125I]-IGF-II binding resulted in nonlinear concave-down Scatchard plots, indicating the presence of high- and low-affinity equilibrium constant of association (Ka) sites. Assuming a preexisting asymmetric model with independent high (KaHi) and low (KaLo) sites; Zn2+, Cd2+, and Au3+ eliminated KaHi and Zn2+, and Au3+ lowered KaLo, compared with control values. The same results were found, independent of whether [125I]-IGF-I or [125I]-IGF-II was used. Similarly, assuming a ligand-induced model of negative cooperativity, all three cations eliminated the initial affinity for the high affinity sites (Ka), whereas Zn2+ and Au2+ reduced the final affinity for the low affinity sites (Kf). Dose-response studies indicated that Zn2+, Au3+, and Cd2+ depressed binding with half-maximal activities of approximately 20 microM, 14-60 microM, and 50-65 microM, respectively. Zn2+, Au3+, and Cd2+ bind to similar sites on proteins (a zinc-binding motif), indicating similar mechanisms of action. A zinc-binding motif is present within the IGFBPs but not the IGFs. We demonstrate, for the first time, that multivalent cations have the potential to modulate IGF activity by decreasing the amount of IGF bound to cell-associated IGFBP-5.
目前的研究量化了多价阳离子锌、镉、镧、铬和金(Zn2+、Cd2+、La3+、Cr3+和Au3+)对[125I] - 胰岛素样生长因子([125I] - IGF)与T98G人胶质母细胞瘤细胞结合的影响。通过亲和标记确定,IGF在T98G细胞上的主要结合位点是IGF结合蛋白-5(IGFBP-5)。使用[125I] - IGF-I或[125I] - IGF-II进行的竞争性结合研究表明,La3+和Cr3+不影响[125I] - IGF-I或[125I] - IGF-II与细胞相关IGFBP-5的结合。Zn2+、Au3+和Cd2+降低了[125I] - IGF-I和[125I] - IGF-II的结合。[125I] - IGF-I和[125I] - IGF-II的结合产生了非线性下凹的Scatchard图,表明存在高亲和力和低亲和力的结合平衡常数(Ka)位点。假设存在一个预先存在的具有独立高(KaHi)和低(KaLo)位点的不对称模型;与对照值相比,Zn2+、Cd2+和Au3+消除了KaHi,Zn2+和Au3+降低了KaLo。无论使用[125I] - IGF-I还是[125I] - IGF-II,都得到了相同的结果。同样,假设存在一个配体诱导的负协同模型,所有这三种阳离子都消除了对高亲和力位点(Ka)的初始亲和力,而Zn2+和Au2+降低了对低亲和力位点(Kf)的最终亲和力。剂量反应研究表明,Zn2+、Au3+和Cd2+降低结合的半数最大活性分别约为20 microM、14 - 60 microM和50 - 65 microM。Zn2+、Au3+和Cd2+与蛋白质上的相似位点结合(锌结合基序),表明作用机制相似。IGFBP中存在锌结合基序,但IGF中不存在。我们首次证明,多价阳离子有可能通过减少与细胞相关IGFBP-5结合的IGF量来调节IGF活性。